Ed DeVaney tabbed as president of CVS Caremark
DeVaney had been named interim president in December 2024. He will report to Prem Shah, group president, CVS Health.
Latest
With cold and flu cases on the rise, Boiron adds throat spray to portfolio
Boiron’s ThroatCalm Spray is Boiron’s newest addition to the cold and flu care market, offering a targeted solution for sore throat relief.
Balmex AdultAdvantage offers relief for varied skin conditions
"At CrossingWell, our Balmex AdultAdvantage skin relief product was designed for this market, and it largely fills an unmet need.”
Some conspicuous absences from Fortune’s list
David Pinto writes that surprising to some and not so surprising to others was the absence of any drug chain from the list.
Video Forum: Krystal Register, FMI – The Food Industry Association
Link between diet and long-term health takes center stage.
Craig Dubitsky and Robert Downey Jr.'s happy products now in Albertsons
happy's rapid and strategic growth has resulted in the brand's presence in more than 60,000 points of distribution in popular big-box retailers, regional grocery stores, and e-commerce platforms.
Jim Tsipakis makes Giant Eagle a holistic space
“Our pharmacy business has never been stronger. We continue to grow and fill the needs of our guests,” Tsipakis says.
Shoppers Foundation for Women’s Health donates $10M to support murdered and missing indigenous women
Donation to Endowment Fund to advance healing and empowerment programs.
Retail sales cool in January after holiday surge
NRF Chief Economist Jack Kleinhenz said the decline was expected.
NRF responds to reciprocal tariffs
NRF has issued a statement about the Trump administration’s plan to impose reciprocal tariffs on all trading partners.
2025 Health Care Outlook: Micah Cost, PQA
By Micah Cost, CEO, Pharmacy Quality Alliance (PQA)
2025 Health Care Outlook: Sandra Hanna, Neighbourhood Pharmacies
By Sandra Hanna, CEO Neighbourhood Pharmacies.
Ana Archbold on Dr. Reddy’s women’s health business
Ana Archbold is responsible for setting and executing the broader strategy for the company’s Self-Care and Wellness division in the U.S.
AAM says Inflation Reduction Act undermines generic and biosimilar competition
The AAM warns that IRA price controls may reduce generics and biosimilars, slowing competition and keeping drug prices high.
RFK Jr. confirmed as health secretary
The senate vote was split nearly along party lines. Industry organizations respond to confirmation.
Sai Life Sciences’ rapid growth fuels successful IPO
The IPO attracted strong interest from institutional investors, with demand exceeding allocation by over thirty times.